Description

Tesamorelin MAX is a high-volume, 60mg formulation of the stabilized GHRH analogue designed for advanced, extended, or large-scale laboratory research requiring maximum analytical capacity. This premium concentration is intended for intensive study protocols, long-duration GH axis investigations, multi-cohort experimental designs, and research environments where sustained Tesamorelin availability is essential. The elevated peptide volume supports comprehensive metabolic modeling, extended dose-response analysis, and complex somatotropic research designs that demand consistent compound availability over time. Tesamorelin MAX is the preferred formulation for research facilities conducting in-depth investigations into visceral fat biology, GHRH receptor pharmacology, and advanced growth hormone modulation research.